November 29, 2016
For the first time, researchers have found higher levels of Gram-negative bacteria antigens in brain samples from late-onset Alzheimer’s disease patients. Compared to controls, patients with Alzheimer's had much higher levels of lipopolysaccharide (LPS) and E coli K99 pili protein. In addition, The UC Davis team also found LPS molecules congregated with amyloid plaques, which have been linked to Alzheimer’s pathology and progression. The research was published today in the print edition of the journal Neurology.
November 29, 2016
Can lifestyle changes help reduce the risk of Alzheimer’s disease and dementia? John Olichney, UC Davis professor of neurology and a behavioral neurologist, will address the question at a public lecture Wednesday, Dec. 7 at 6:30 p.m. at the Lesher Center for the Arts in Walnut Creek.
October 26, 2016
One of the major unsolved mysteries in neuroscience is how synapses are eliminated in the brain during normal development. This pruning process is required for precise brain wiring, but what drives the elimination of specific synapses remains unclear. Neuroscientist Beth Stevens will explore her recent research, which revealed a key role for microglia in synaptic pruning in a free public lecture at the UC Davis MIND Institute on Nov. 9. at 4:30 p.m.
October 20, 2016
Two UC Davis researchers have received grants totaling $1.6 million to advance their work to find an effective treatment for Angelman syndrome, a rare genetic disorder that causes seizures and sleep disturbances and inhibits language development.
October 18, 2016
John Morrison, professor of neurology at the University of California, Davis, and director of the California National Primate Research Center, has been elected to the National Academy of Medicine, one of the world’s most prestigious scientific bodies.
October 13, 2016
The National Institutes of Health (NIH) has named the California Precision Medicine Consortium as a regional medical center group in the national network of health care provider organizations that will implement the Precision Medicine Initiative (PMI) Cohort Program.
October 3, 2016
An understanding of the effect of nutrients on brain structure and cognitive development in infants and children has advanced maternal and infant nutrition over the past two decades.
September 23, 2016
The UC Davis Alzheimer’s Disease Center, which investigates cognitive aging and dementia, has received renewed funding of $6.9 million from the National Institute on Aging (NIA).
September 22, 2016
The UC Davis Alzheimer's Disease Center Community Engagement lecture featuring Denise Park of the University of Texas has been canceled for this evening, Thursday, Sept. 22, at 6 p.m., at the UC Davis MIND Institute. Dr. Park's lecture will be rescheduled in the future.
September 7, 2016
The road to treating children with autism is still being paved, and while scientific, regulatory and other obstacles may slow progress, families and researchers alike are determined to forge ahead.
Cognitive function tests reliable for people with intellectual disabilities, UC Davis research shows
September 6, 2016
Researchers at the UC Davis MIND Institute have found that a battery of tests appears to have strong potential for measuring cognitive changes over time for people with intellectual disabilities. The work could open new doors to research into whether drugs and specialized educational programs or treatments can improve function in people with Down syndrome, fragile X syndrome and other causes of intellectual disabilities.
August 26, 2016
Treatment with sertraline may provide nominal but important improvements in cognition and social participation in very young children with fragile X syndrome, the most common genetic cause of intellectual disability and the leading single-gene cause of autism, a study by researchers with the UC Davis MIND Institute has found.
August 9, 2016
To better serve its patients, UC Davis Medical Group has merged its midtown outpatient services in Sacramento and some pediatrics care services into a larger, nearby facility on Folsom Boulevard.
August 4, 2016
Charles DeCarli, director of the UC Davis Alzheimer’s Disease Center, will give a presentation on “New Diagnostic Tools for Alzheimer’s Disease” on Tuesday, Aug. 16, from 6:30 p.m. until 7:30 p.m. at the Lesher Center for the Arts, 1601 Civic Drive in Walnut Creek, Calif.
August 2, 2016
Four cutting-edge studies, including one led by John Olichney, professor and neurologist at the UC Davis Alzheimer’s Disease Center, will each receive $1 million to advance current Alzheimer's research to the next stage of clinical trials. A unique, goal-driven competition offers an additional $3 million to the clinical trial that demonstrates the most promise for treating this devastating disease.
July 27, 2016
The UC Davis MIND Institute kicks off its 2016-2017 Distinguished Lecturer Series in September with an address by Robert H. Ring, associate professor at Drexel University in the College of Medicine, Department of Pharmacology and Physiology.
July 19, 2016
UC Davis researchers have found a way to get MRI images of children with autism spectrum disorder (ASD) and intellectual disability without sedating them first using the principles of applied behavior analysis.
July 18, 2016
Adding to its growing portfolio of important federal grants to address the needs of people with developmental disabilities, the UC Davis MIND Institute, in collaboration with California State University Sacramento, has been awarded $2.7 million, to be spent over five years, to train professionals and family members who care for people with autism spectrum disorder (ASD) and other neurodevelopmental disorders.
July 14, 2016
Physical exams conducted from the 1960s through the 1980s will be revisited to evaluate risks and protective factors in early and midlife that could affect brain health and dementia diagnoses among a large, ethnically diverse group of seniors. The Kaiser Permanente Northern California Division of Research will partner with the UC Davis Alzheimer’s Disease Center for the study, which is funded with a five-year, $13 million grant from the National Institute on Aging.
MIND Institute researcher studies feasibility of community providers training parents of children with autism
June 22, 2016
Research has long shown that parent-implemented “naturalistic developmental behavioral interventions,” which are applied in a child’s usual setting and designed to build developmentally appropriate skills, help decrease the main symptoms of autism spectrum disorder (ASD). However, parent training by community providers had not previously been studied.
June 13, 2016
The Northern California Chapter of the Huntington’s Disease Society of America (HDSA) recently honored Teresa Tempkin, co-director of the HDSA Center of Excellence at UC Davis, for her nearly 18 years of service to patients with Huntington’s disease and their families in Sacramento and the nation. The honor was presented during the chapter’s annual convention, held at the UC Davis MIND Institute.
May 27, 2016
Grade school is an important period in children’s development, when they begin to mature and prepare to enter adolescence. Now, researchers with the UC Davis MIND Institute hope to discover how to maximize that growth among children with autism to help them learn and thrive.
May 26, 2016
UC Davis Medical Center has been recognized by the American Heart Association/American Stroke Association for using evidence-based guidelines that improve care and quality of life for stroke patients.
May 25, 2016
The UC Davis Alzheimer’s Disease Center has established a new, integrated translational cognitive neuroscience postdoctoral fellowship program through a five-year, $1 million grant from the National Institute on Aging.
May 23, 2016
“Depression in Alzheimer’s disease: Cause or consequence?” is the topic of the UC Davis Alzheimer’s Disease Center’s June 2016 Community Discovery Lecture Series presentation.
May 18, 2016
Kwan L. Ng, assistant professor and director of vascular neurology at UC Davis Health System, has been named director of the UC Davis Stroke Center.
May 10, 2016
With the dramatic rise of children diagnosed with autism spectrum disorder (ASD), the numbers and types of interventions promoted to families and individuals with autism have surged as well.
May 4, 2016
Three UC Davis Health System teams have been selected from among 54 highly competitive proposals to receive awards to develop innovative information technology solutions in human health care from the Center for Information Technology Research in the Interest of Society — CITRIS — a collaboration of the UC campuses at Berkeley, Davis, Merced and Santa Cruz. The grants are awarded in collaboration with the Banatao Institute founded by high-tech entrepreneur and philanthropist Dado Banatao.
April 27, 2016
Sean Sawicki, who has fragile X syndrome, can be hard to understand and doesn’t always have the attention span to carry on a sustained conversation. But a novel intervention developed by UC Davis MIND Institute researchers seems to be making a difference.
April 21, 2016
The UC Davis MIND Institute in Sacramento, Calif. today helped launch SPARK, an online research initiative designed to become the largest autism study ever undertaken in the United States. Sponsored by the Simons Foundation Autism Research Initiative (SFARI), SPARK will collect information and DNA for genetic analysis from 50,000 individuals with autism — and their families — to advance our understanding of the causes of this condition and to hasten the discovery of supports and treatments. [español]
UC Davis Health System NIA-funded research centers discuss diversity, disparities and cognitive aging
April 5, 2016
The National Institute on Aging (NIA)-funded UC Davis Latino Aging Research Resource Center (LARRC) and Alzheimer’s Disease Center hosted an all-day conference on March 16, 2016 on “Cognitive Aging and Diversity: Progress and Future Challenges." The conference highlighted NIA-funded research in Northern California associated with UC Davis and UC San Francisco, and brought together leading national experts from across the country. Approximately 80 participants attended.
March 24, 2016
Antipsychotic medications are prescribed to Hispanics with Alzheimer’s disease or other dementias at higher rates than non-Hispanic whites, for dementia-related mental-health symptoms such as depression, anxiety and aggression, a UC Davis study conducted using data from a large and diverse population of elderly dementia patients has found.
March 15, 2016
In a promising finding for research into Huntington’s disease (HD) — the devastating inherited neurodegenerative disorder — a team of UC Davis investigators has identified for the first time a way to use human mesenchymal stem cells (MSCs) to deliver the key brain protein growth factor that is dramatically diminished by Huntington’s disease.
February 25, 2016
Technology may not have caught up to the teleportation devices of science fiction, but now we have some idea of how the brain handles “beaming up” from one location to another, thanks to research by neuroscientists at the University of California, Davis, involving some specially wired volunteers.
February 23, 2016
People who exercise have better mental fitness, and a new imaging study from UC Davis Health System shows why. Intense exercise increases levels of two common neurotransmitters — glutamate and gamma-aminobutyric acid, or GABA — that are responsible for chemical messaging within the brain.
February 22, 2016
The UC Davis MIND Institute, in partnership with Lynn and Keith Volkerts and the George and Lena Valente Foundation, will host an “Afternoon of Discovery and Discussion” on Sunday, March 6.
UC Davis MIND Institute Distinguished Lecturer Series features renowned neuroscientist Karl Deisseroth
February 8, 2016
Neuroscientist Karl Deisseroth, the D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences at Stanford University, will discuss “Illuminating the Brain in Health and Disease” during the next UC Davis MIND Institute Distinguished Lecturer Series presentation on Wednesday, Feb. 10, at 4:30 p.m.
January 13, 2016
UC Davis’ leadership in Huntington’s disease research received another boost recently when Kyle Fink, a post-doctoral fellow at the Institute for Regenerative Cures, was recognized by the American Academy of Neurology (AAN) for the cutting-edge research findings in gene editing that he presented at the 2015 Society for Neuroscience Annual Meeting.